Friday, June 18, 2010

Brainware Brings Distiller Platform to HFMA's 2010 ANI Conference in Las Vegas

Intelligent Data Capture Solution to Be Showcased for Preeminent Members of the Healthcare Finance Community

Brainware, Inc., the leading provider of intelligent data capture and enterprise search solutions,
will be showcasing its Brainware Distiller™ platform at the Healthcare Financial Management Association’s 2010 ANI: The Healthcare Finance Conference at the Sands Expo Center and Venetian/Palazzo Resort in Las Vegas, Nevada from June 20-23, 2010.

Brainware will be exhibiting with Surgical Information Systems and Sunquest Information Systems, and will present its Distiller solution to a number of representatives of distinguished, results-driven healthcare organizations.  In addition to its cutting edge contributions to A/P efficiency, financial visibility and profit maximization, Distiller streamlines Explanation of Benefits (EOB) processing, a solution that is uniquely suited to healthcare providers and offers superlative workflow performance.

As the tried and proven Accounts Payable automation solution for a number of major healthcare providers, payers and vendors, including Baylor Health Care System, Yale New Haven Health Care System, National Health Service (NHS) of the United Kingdom, bioMérieux, TriZetto, Amgen, Alcon, Abbott Labs, Kimberly-Clark and others, Brainware Distiller brings a wealth of opportunity to the healthcare industry, minimizing the costs of manual data entry and bill processing, freeing up dollars that may be better spent on patient care, medical research and pharmaceutical development.

“The HFMA 2010 Conference brings together the foremost leaders in modern healthcare providers,” says Charles Kaplan, VP of Marketing at Brainware. “Automation is the way of the future for Accounts Payable, and this event gives us the opportunity to demonstrate how the Distiller data capture solution can maximize A/P efficiency, free up early payment discounts, reduce errors and late payment penalties, and unlock otherwise hidden value that benefits patients and shareholders alike.”

No comments: